Back

Distribution and temporal trends of predicted ten-year and lifetime atherosclerotic cardiovascular disease risk in Chinese adults, 2013-2023: national cross-sectional surveys

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment Cardiovascular Risk Assessment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Assistant Professor Chun Li

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

5 More presentations in this session

Presentation thumbnail
Relationship between cumulative exposure to systemic inflammation response index and risk of all-cause mortality in middle-aged and older adults with cardiovascular-kidney-metabolic syndrome stage 0–2
Professor R. Huang (Beijing, CN)
Abstract
Presentation thumbnail
The association of multi-system health status and its longitudinal changes with cardiovascular disease risk: insights from multinational cohorts study
Miss Y. Xin (Beijing, CN)
Abstract
Presentation thumbnail
Uncontrolled cardiometabolic risk factors and risk of cardiac dysfunction in psoriasis: the PSOCADIA study
Miss C. Jansen (Hellerup, DK)
Abstract
Presentation thumbnail
Associations between a body shape index and cardiometabolic risk markers: age- and sex-specific patterns in a Brazilian population
Doctor T. Minari (Sao Paulo, BR)
Abstract
Presentation thumbnail
Cardiovascular risk factor control after implementation of mandatory risk assessment in a tertiary cardiovascular centre
Miss A. Palikuca (Novi Sad, RS)
Abstract

Access the full session

Session thumbnail
Cardiovascular risk assessment

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Distribution of cardiovascular disease risk in adults aged 40 to 79 years with diagnosed hypertension but not on medications: findings from nationwide cross-sectional studies
25 April 2024
thumbnail
Congress Presentation
VICTORION-Mono China: efficacy and safety of inclisiran as monotherapy in Chinese adults with low or moderate ASCVD risk and elevated LDL-C
29 August 2025
thumbnail
Congress Presentation
Temporal trends and outcomes of cardiac rehabilitation after acute coronary syndrome in an asian population
4 April 2025
thumbnail
Congress Presentation
Serum proteomic profiling of carotid atherosclerosis: a population outcome study
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources